Hans Menssen joins Priothera

Company
Priothera Ltd
Appointee name
Hans Menssen
Country

Ireland

Priothera Ltd, a late-stage biopharma company developing a potential standard of care, mocravimod, in haematologic cancers, has appointed Hans Menssen to its board. A haematologist and oncologist, Dr Menssen most recently was senior global programme clinical head at Novartis Oncology and has held senior roles at Bayer Schering Pharma and Philogen SpA.

Copyright 2025 Evernow Publishing Ltd